Patients with pre-existing cardiovascular disease, hypertension, or arrhythmias would face potentially elevated risks, though the exact nature of any interaction remains unstudied
As a result, they dont believe weightloss drugs are medically necessary
Semaglutide works by activating GLP-1 receptors in the brain, reducing appetite and slowing stomach emptyingbut the medication doesn't eliminate the need for thoughtful eating
Some patients using compounded semaglutide injections report a decrease in their appetite in just about a week, but noticeable weight changes typically occur over several weeks to months
Deciding whether to include soda on a GLP-1 diet isnt about strict rules
Additionally, patients receiving GLP-1 medications often have metabolic conditions that independently affect cancer risk, making it challenging to isolate drug effects